This content is machine translated Abdominal wall sparing training after visceral surgical procedures Physical reconditioning and wound healing hand in hand Visceral surgery patient volumes have increased significantly in recent years. After major surgery with opening of the abdominal wall due to chronic, oncological or acute diseases, almost all patients suffer…
View Post 4 min This content is machine translated Metastatic colorectal cancer Comparison between bevacizumab and cetuximab in KRAS exon2 wild type. According to preliminary results of a large phase III trial presented at this year’s ASCO congress, bevacizumab and cetuximab (combined with FOLFOX or FOLFIRI) show similar efficacy in terms of…
View Post 2 min This content is machine translated Gastric and esophageal cancer The scar heals, the questions remain As a therapist in oncology rehabilitation, I once encountered a patient who quoted her surgeon as saying, “I was able to remove your tumor completely. You are healthy again.” At…
View Post 9 min This content is machine translated Esophageal and gastric cancer Perioperative adjuvant radio-chemotherapy T1-T2 N0 tumors undergo primary surgery. Proximal esophageal cancer is an indication for radio-chemotherapy alone (RCT). In contrast, T3-T4 and N+ carcinomas are treated trimodally when possible. Neoadjuvant RCT increases…
View Post 3 min This content is machine translated Bronchiectasis A bronchial change that accompanies numerous diseases Bronchiectasis, irreversible dilatation of the bronchi, accompanies many diseases but can also be congenital. If one wants to therapeutically address the entire clinical picture with all its symptoms (bronchiectasis), one…
View Post 3 min This content is machine translated Unwanted weight loss Evidence-based approach in practice Why do people lose weight unintentionally? This question was discussed in a workshop at the ESCIM Congress in Geneva. Seniors in particular often come to the family doctor’s office with…
View Post 2 min This content is machine translated German-speaking European School of Oncology in St. Gallen The pros and cons of antiangiogenic therapy in first-line treatment. At a DESO advanced training course in St. Gallen, Prof. Volker Heinemann, MD, Munich, and Prof. Werner Scheithauer, MD, Vienna, led a discussion on the use of first-line antiangiogenic therapies.…
View Post 3 min This content is machine translated 2nd EORTC St. Gallen Gastrointestinal Cancer Conference 2014 VEGF inhibition in metastatic colorectal cancer. The use of the VEGF inhibitor bevacizumab improves the outcome of patients with metastatic colorectal cancer regardless of the chemotherapy chosen. Recent data suggest that the duration of VEGF inhibition…
View Post 12 min This content is machine translated Neuroendocrine tumors Not as rare as you might think Neuroendocrine tumors (NET) are not that rare. The prevalence of these tumors in the gastrointestinal tract is exceeded only by colon carcinoma. Often NETs are not detected until the late…
View Post 10 min This content is machine translated Medication with proton pump inhibitors What are the opportunities and risks? Proton pump inhibitors (PPIs) are the third most commonly used class of drugs in current clinical practice worldwide after antibiotics and statins (Table 1). These highly potent acid inhibitors effectively cure…
View Post 5 min This content is machine translated Second St. Gallen EORTC Conference Multimodality treatment of advanced rectal cancer. Which drugs are suitable for neoadjuvant radiochemotherapy? If there is a complete clinical response, should we wait or operate? And which patients benefit from adjuvant treatment? These were some of…
